ArticleJournal of ophthalmology2026
Clinical and Meibomian Lipidomic Changes After Combined Intense Pulsed Light and Triamcinolone Acetonide Therapy for Chalazion: A Retrospective Single-Arm Pre-Post Case Series.
Article in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To explore the clinical changes associated with intense pulsed light (IPL) combined with triamcinolone acetonide (TA) injections in patients with chalazion and to evaluate associated changes in Hospital Anxiety and Depression Scale (HADS) scores and meibomian gland lipid profiles. Methods: This study was designed as a retrospective single-arm pre-post case series involving 15 adult patients with chalazion who had not received alternative treatments for at least three months. No control group was included. The primary outcome was complete resolution of chalazion at the final follow-up (T2). Secondary outcomes included changes in ocular surface parameters (OSDI, TBUT, CFS, and SIT), psychological status assessed using the HADS, and alterations in meibomian gland lipid composition evaluated by lipidomic analysis. Results: All patients met the predefined criteria for complete chalazion resolution at the final follow-up (T2). Significant improvements were observed, with OSDI scores decreasing from 26.27 ± 5.11 to 16.6 ± 10.42, TBUT increasing from 3.23 ± 1.05 to 7.53 ± 2.75 s, and CFS reducing from 1 ± 1.13 to 0.27 ± 0.7. Depression (HADS-D) and anxiety (HADS-A) scores also decreased significantly. The SIT increased from 9.87 ± 5.05 to 11.27 ± 7.32, though not statistically significant. Lipidomics analysis identified 719 lipids, with significant reductions in sphingolipids (Cer and SM) and glycerophospholipids (LPC, LPE, PC, and PE) posttreatment ( Conclusion: In this retrospective single-arm pre-post case series, IPL combined with TA treatment was associated with the resolution of chalazion and improvements in several clinical and lipidomic parameters. However, these findings should be considered exploratory and interpreted with caution, as spontaneous chalazion resolution and concurrent warm compress therapy may have contributed to the observed changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.